Archive

Cernostics, a diagnostics company delivering next generation cancer diagnostics through a unique approach to tissue analysis, announced today that the United States Patent and Trademark Office has issued two patents, US Patent 8,114,615 and US Patent... Read more

Cancer diagnostics company Cernostics announced Tuesday it had received two patents in the United States and a third patent in Japan.... Read more